Press Room

Share

Senate Committee Preserves FDA Authority Over Tobacco Products, Boosts Funding for Oncology Center of Excellence

May 24, 2018

Washington, D.C.  – The U.S. Senate Committee on Appropriations today approved its FY 2019 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies appropriations bill. The bill preserves the Food and Drug Administration’s (FDA) authority over tobacco products and also boosts funding for FDA’s Oncology Center of Excellence (OCE) by $5 million. The OCE was created by the 21st Century Cures Act and works ensure that the patient perspective is considered in the regulatory decision-making process through a patient-focused drug development program.  It also creates a unified and collaborative scientific environment to quickly advance the development of innovative and effective oncology products for cancer patients.

A statement from Chris Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN) follows:

“We commend the Senate committee for preserving FDA’s ability to protect the public health by allowing the agency to adequately regulate all tobacco products, including products that have come to market since the passage of the Family Smoking Prevention and Tobacco Control Act of 2009.

“Additionally, ACS CAN was pleased to see the committee boost funding for FDA’s Oncology Center of Excellence in the upcoming fiscal year.

“We applaud the committee for adopting a clean bill and rejecting proposals that were attached to the House version of this bill that would undercut FDA’s oversight authority of tobacco products. We call on lawmakers to adopt the Senate spending bill when it comes up for consideration before the full Congress later this year.”

###

More Press Releases AboutCancer Research Funding

Media Contacts

Mike VanDenHeuvel
Senior Manager, Media Advocacy
Washington, D.C.
[email protected]
202-585-3246

Related Press Releases

March 21, 2024

Congress Considers FY24 Appropriations Bill That Prioritizes Cancer Research and Proven Cancer Screening Funding Amidst Difficult Budget Cycle

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program. 

Read More
March 24, 2023

New Jersey is taking a giant leap forward in the war against cancer. Here's how

The following originally appeared in the Asbury Park Press on March 24, 2023.

 

Read more
March 11, 2024

President’s FY25 Budget Prioritizes Funding for Cancer Research and Prevention

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.

Read more